Cardiff Oncology is a San Diego biotechnology company developing onvansertib, an oral drug for several cancers. It last closed at $0.85 on Nov 20, down 4.46% on the day. The next earnings report for CRDF is expected around Thu, Feb 11, 2027, after the close. For the quarter ended Sep 2026, CRDF reported EPS of -$0.12 on revenue of $171,000, with revenue up 42.5% from a year ago. Over its last 8 reports the stock moved an average of 8.4% the session after earnings. Over the last 12 months CRDF insiders bought $1.1M of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is CRDF in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CRDF.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on CRDFStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
CRDF · as of the Nov 20 close · updated each morning
Downtrend
The stock sits between its 20 and 50 day averages. It is 56% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 48). The nearest support is the 20 day average at $0.83, and the nearest resistance the Pivot at $0.86.
Short trendBearish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityHigh, 9.2%/day
Key levels
$3.3152 week high+289.4%
$1.33200 day average+56.5%
$1.0150 day average+18.8%
$1.01100 day average+18.8%
$0.94Swing high (Nov 16)+10.6%
$0.89Pivot R1+4.7%
$0.86Pivot+1.2%
$0.85Last close
$0.8320 day average−2.4%
$0.82Pivot S1−3.5%
$0.78Swing low (Oct 27)−8.2%
$0.7152 week low−16.5%
Indicators
RSI (14)
47.57
Middle of its range
Neutral
MACD
-0.04
Above its signal line
Bullish
Stochastic
66.6
Middle of its range
Neutral
ADX (14)
27.1
Trending up
Williams %R
-37.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
42.5
Oversold below −100, overbought above 100
Neutral
Rate of change
+7.2%
Change over 10 sessions
Bullish
ATR (14)
$0.08
Typical daily range, 9.2% of price
MA 10Above
MA 20Above
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityNormal, 23.6%/day
Key levels
$3.3152 week high+289.4%
$1.33200 day average+56.5%
$1.0150 day average+18.8%
$1.01100 day average+18.8%
$0.94Swing high (Nov 16)+10.6%
$0.89Pivot R1+4.7%
$0.86Pivot+1.2%
$0.85Last close
$0.8320 day average−2.4%
$0.82Pivot S1−3.5%
$0.78Swing low (Oct 27)−8.2%
$0.7152 week low−16.5%
Indicators
RSI (14)
39.55
Weak, oversold below 30
Neutral
MACD
-0.19
Below its signal line
Bearish
Stochastic
8.6
Near the bottom of its range
Oversold
ADX (14)
15.1
No clear trend
Williams %R
-82.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-71.4
Oversold below −100, overbought above 100
Neutral
Rate of change
−29.5%
Change over 10 sessions
Bearish
ATR (14)
$0.20
Typical daily range, 23.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CRDF
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CRDF did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow CRDF usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for CRDFHow many large options trades hit CRDF, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in CRDF in the last 90 days.
From SEC Form 4 filings by CRDF's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CRDF is in one of them and how their past CRDF trades turned out.
Cardiff Oncology is a biotechnology company based in San Diego, California, that develops cancer treatments. Its lead candidate, onvansertib, is an oral drug designed to block the PLK1 enzyme, and it is tested alone and alongside standard cancer therapies. The company is running studies in colorectal, pancreatic, lung, breast and blood cancers, focusing on patients whose tumors carry certain genetic markers.